Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

The requested reference [3910554893f7a53bc9a8872025790265d0f1ae6c] no longer exists in our database. It has been replaced by the current reference: [a09c2851190f47023e24683b951d4bb7c6766310]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is a mechanistic randomized controlled trial that investigates whether inhibition of tumor necrosis factor signaling via intravenous infusion of infliximab improves psychomotor speed and executive functioning in depressed individuals who exhibit an inflammatory phenotype.
Epistemonikos ID: 6861f2c9e377fe22ff8b068ecf65fb8edc9651ad
First added on: May 15, 2024